Piperacillin-tazobactam reduces surgical site infections compared to cefoxitin, impacting long-term surgical outcomes for pancreatoduodenectomy patients. Patients on piperacillin-tazobactam had lower surgical site infection rates, improving postoperative recovery. No significant differences in chemotherapy omission rates between the two antibiotic groups (9.4% vs. 15.4%). Surgical site infections correlated with poorer 3-year overall survival (HR 1.69). Improving antibiotic […]
Category: HPB & Spleen
Risk Factors for Early Mortality in Resected Localized Pancreatic Cancer
Identifying early mortality risks can guide surgical decisions in pancreatic cancer patients post-neoadjuvant treatment. 10.5% of patients experienced disease-related death within 12 months after radical resection. Tumor size ≥ 25 mm and CA19-9 levels ≥ 100 U/ml significantly predict early death risk (OR 3.81 and 2.93, respectively). Surgeons should closely evaluate these factors during preoperative […]
Immediate Endoscopic Necrosectomy Cuts Recovery Time in Pancreatitis
Immediate endoscopic necrosectomy (den) after drainage significantly speeds recovery in patients with necrotizing pancreatitis. Time to clinical success was 29 days with immediate den, compared to 44 days with the step-up approach (p = .009). Adverse events were similar between groups: 24% for immediate den vs. 22% for step-up (p = .79). Consider immediate den […]
Revised approach to gallbladder and sphincter disorders
More accurate diagnosis is shifting surgical practice for abdominal pain and pancreatitis. New criteria for dysfunctional gallbladder disorder (DGBD) focus on typical biliary pain and symptom persistence. Sphincter of Oddi disorder (SOD) now requires objective evidence of obstruction or pancreatitis. Surgeons should be cautious, as these disorders are often over-diagnosed, leading to unnecessary risky treatments. […]
Lymph Node Yield Linked to Survival in Node-Negative PDAC
Lymph node yield significantly impacts overall survival and time to recurrence in node-negative pancreatic ductal adenocarcinoma after neoadjuvant therapy. Lymph node yield of 22 or more nodes correlates with a median survival of 59 months compared to 25 months for fewer nodes (p < 0.001). In a large cohort, those with lymph node yield ≥ […]
ISGPS Class D Increases Pancreatic Fistula Risk After Surgery
A new classification system helps predict pancreatic fistula risk after pancreatoduodenectomy. Overall postoperative pancreatic fistula (POPF) rate is 19.9%. Class D patients have a 37.4% POPF rate, significantly higher than Class A’s 9.0% (p < 0.001). Surgical decision-making should incorporate this classification for better patient selection. Class D patients show a 6-fold increased risk of […]
Selective Drain Use After Pancreatic Resection Shows No Harm
Selective omission of operative drains in pancreatic surgeries doesn’t worsen perioperative outcomes. In a study of 2,607 patients (1,855 pancreaticoduodenectomy, 752 distal pancreatectomy), outcomes with and without drains were comparable. Complications, 90-day mortality, and hospital stays were similar for those with a clinically relevant pancreatic fistula: no significant differences were found. Notably, patients without a […]
Perioperative Quality of Life Dynamics in Pancreatic Cancer Patients
Surgeons need to consider how perioperative quality of life fluctuates in pancreatic cancer patients to enhance outcomes. Quality of life scores significantly change between perioperative stages (p < 0.001). Main issues needing attention: pain and nausea in the first week, social functioning before discharge, and fatigue one month post-op. Timely interventions on these factors can […]
Surgery Outperforms Chemotherapy for Advanced Pancreatic Cancer
Surgical resection significantly enhances survival in borderline resectable and locally advanced pancreatic cancer compared to continued oncology therapy. Median overall survival (OS) is 39.0 months after resection versus 16.7 months with oncology therapy (p < 0.0001). In a matched cohort, OS is 42.6 months with resection compared to 18.6 months with oncology therapy (p < […]
New stapler method cuts pancreatic fistula risk in surgery
This study shows that using a stapler for pancreatic transection in robot-assisted pancreaticoduodenectomy reduces clinically relevant postoperative pancreatic fistulas. The stapler method group had a cr-popf incidence of 13.1% compared to 31.5% in the conventional group (p=0.014). Body mass index is a risk factor for cr-popf (OR 1.34), while the stapler method reduced risk (OR […]